Dr. Lu Si has long been engaged in the clinical management and translational research of melanoma, sarcoma, and genitourinary tumors. She has extensive experience in tumor immunotherapy, targeted therapy, and mechanistic research related to these fields. Dr. Si has published numerous high-impact papers in leading international journals, including Journal of Clinical Oncology, JAMA Oncology, Nature Communications, and Signal Transduction and Targeted Therapy (STTT), and has been recognized with an H1Connect Top 0.5% recommendation.
She has led more than ten major national research projects, including the National Science Fund for Distinguished Young Scholars, key programs of the Ministry of Science and Technology, and grants from the Ministry of Education. Dr. Si is regarded as one of the key academic contributors advancing melanoma and sarcoma research in China.
